Meeting of minds: Advancing research into neurological disease diagnosis and treatment

In this insightful eBook about innovation in neurological diseases, NervGen joins forces with Jean-Charles Lambert, PhD, from Institut Pasteur de Lille, INSERM and Professor Ben Freedman from the Heart Research Institute to explore their latest research in greater detail.

Neurological diseases have long carried a significant burden on individuals, their families, carers, and the global healthcare system. There are over 250 recognised neurological diseases affecting millions of people worldwide.

These diseases not only drastically impact the quality of life of patients, but they are also causing mortalities in enormous numbers. The World Health Organization reported that between 2000 and 2019, Alzheimer’s disease and other forms of dementia, two major neurological diseases, ranked third in both America and Europe in the top 10 causes of death.

This emphasises how powerful new research into the diagnosis and treatment of neurological diseases genuinely is. Offering new diagnosis tools that could revolutionise therapeutic care, speed up the analysis process and detect neurological conditions at an earlier stage could alleviate the growing difficulties for affected individuals, families, and healthcare systems. Whereas innovations in treatment options, such as the NervGen drug candidate, could unlock promising opportunities to grow the portfolio of existing therapeutics.

Paving the way for an inventive future for neurological disease patients

This comprehensive eBook, featuring insightful research from experts in the field of neurology, will delve into a selection of key revolutions surrounding neurological diseases, such as Alzheimer’s disease and dementia, and how innovations are shaping the world of diagnoses and treatment options.

Within this eBook, you will find contributions from:

  • Jean-Charles Lambert, PhD, Research Director at the Institut Pasteur de Lille, INSERM;
  • Bill Radvak, NervGen Pharma Corp and;
  • Professor Ben Freedman OAM, Director of External Affairs, Heart Research Institute, Group Leader of the Heart Rhythm and Stroke Prevention Group.


Please enter your comment!
Please enter your name here